Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients
Liancheng Fan; Rui Wang; Chenfei Chi; Wen Cai; Yong Zhang; Hongyang Qian; Xiaoguang Shao; Yanqing Wang; Fan Xu; Jiahua Pan; Yinjie Zhu; Xun Shangguan; Lixin Zhou; Baijun Dong; Wei Xue
Author Information: Department of Urology, Renji Hospital, School of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.